Statement from FDA Commissioner Scott Gottlieb, M.D., on ongoing efforts to stop the spread of illicit opioids, further secure the U.S. drug supply chain and forcefully confront opioid epidemic

February 12, 2019 – The opioid epidemic continues to be one of the greatest challenges facing this nation and the FDA. As we continue to take a range of steps to forcefully confront the opioid crisis plaguing our country, most people think first and foremost about the agency’s work to encourage more appropriate prescribing to decrease exposure to opioids and prevent new addiction, as well as our initiatives to advance innovations in both novel pain therapies and better … (leggi tutto)